![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » LumiraDx’s COVID-19 Antigen Test Expands Indication to Asymptomatic People
LumiraDx’s COVID-19 Antigen Test Expands Indication to Asymptomatic People
The FDA has granted an expanded Emergency Use Authorization for LumiraDx’s COVID-19 antigen test to include testing of asymptomatic people.
In asymptomatic individuals, the 12-minute test was 82.1 percent agreement on positive results and 100 percent agreement on negative results, when compared with results from a laboratory polymerase chain-reaction test, according to the UK-based company
LumiraDx said it has the manufacturing capacity to “enable rapid, high-sensitivity mass screening programs” in schools, events, travel and other settings.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct